Technology Feasibility Assessment for Viral Nervous Necrosis Prevention and Management
A leading biotechnology firm engaged Stellarix for competitive benchmarking and technology feasibility assessment. Our strategic insights helped the client accelerate market readiness by identifying gaps and pinpointing scalable innovations in aquaculture, specifically supporting the development of commercial vaccines for VNN (Viral Nervous Necrosis). Client Background: A Global life sciences and biotechnology conglomerate specializing in sustainable […]